相关实验视频
Updated: Jan 21, 2026

High-Throughput In Vitro Assay using Patient-Derived Tumor Organoids
Published on: June 14, 2021
患者衍生的三维瘤器官模型用于体外化学抗原受体T细胞查
Linjun Liang1, Yue Shi2, Minzhu Ji3
1Department of Oncology, Shenzhen Qianhai Shekou Free Trade Zone Hospital.
这项研究引入了一种新的体外模型,使用患者衍生的结直肠癌器官和仿真抗原受体T (CAR-T) 细胞来评估CAR-T对固体瘤的疗效.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 生物技术是生物技术.
背景情况:
- 化学抗原受体T (CAR-T) 细胞疗法在血液癌症中表现有前途,但在固体瘤中面临挑战.
- 患者衍生瘤器官为药物测试提供了一个3D体外模型,反映了患者的异质性.
研究的目的:
- 在实体瘤中使用患者衍生的结直肠癌器官来建立和验证CAR-T细胞疗法的体外疗效测试模型.
- 评估CAR-T细胞对3D瘤有机体的直接细胞毒性影响.
主要方法:
- 结肠直肠癌患者的样本被用于生成3D瘤器官.
- 瘤器官与CAR-T细胞共同培养,效应与标 (E:T) 比率各不相同.
- 形态变化和死细胞染色被用来评估CAR-T细胞介导的瘤杀死.
主要成果:
- 共同培养系统有效地允许观察CAR-T细胞与3D瘤有机体的相互作用.
- 死细胞染色表明CAR-T细胞对有机体的细胞毒性影响.
- 该模型证明了评估CAR-T细胞瘤杀伤活性的潜力.
结论:
- 这种共同培养模型提供了一种可行的方法来评估CAR-T细胞对患者衍生的结直肠癌器官的疗效.
- 该模型有助于在3D体外环境中研究CAR-T细胞与瘤相互作用.
- 这种方法可以帮助开发用于固体瘤的CAR-T细胞疗法.
更多相关视频
08:04In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function
Published on: February 27, 2019
08:42Establishment of a Co-culture System of Patient-Derived Colorectal Tumor Organoids and Tumor-Infiltrating Lymphocytes (TILs)
Published on: June 27, 2025
相关概念视频
Diversity of Antigen Receptors
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Antigen Presenting Cells
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...
The Two-State Receptor Model
The binding affinity of a drug determines its interaction with...
Types of Receptors: Cell Surface Receptors
Internal Receptors
Receptor-mediated Endocytosis